SCHEMBL2381904

SCHEMBL2381904

Nc1nccc(CN2CCOCC2)c1Cl

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2A13 Q16696 8/20 0.55
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
METAP2 P50579 1/20 0.48
PAX8 Q06710 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CYP2C9 P11712 1/20 0.46
ALOX15 P16050 1/20 0.46
HSD17B10 Q99714 1/20 0.46
HRH3 Q9Y5N1 1/20 0.44
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CXCR4 P61073 1/20 0.41
PLK4 O00444 1/20 0.41
KDM4E B2RXH2 1/20 0.41
HIF1A Q16665 1/20 0.41
JAK2 O60674 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL921683 0.81 MEN1 (0.57) ALDH1A1MEN1KMT2AKDM4E
SCHEMBL27854561 0.78 CYP2A13 (0.53) CYP2A13NPC1RAB9AMETAP2PAX8
SCHEMBL27922987 0.74 SMN1; SMN2 (0.46) CYP2A13NPC1RAB9AMETAP2PAX8
SCHEMBL6179848 0.74 METAP2 (0.37) NPC1RAB9AMETAP2ALDH1A1MEN1
SCHEMBL1565830 0.73 SIGMAR1 (0.41) L3MBTL1HRH3ALDH1A1MEN1KMT2A
SCHEMBL14875501 0.72 AOC1 (0.49) CYP2A13CYP2C9ALOX15HSD17B10HRH3
SCHEMBL12907967 0.72 SIGMAR1 (0.56)
SCHEMBL4105461 0.71 CYP2A13 (1.00) CYP2A13CYP2C9ALOX15HSD17B10ALDH1A1
SCHEMBL31428721 0.71 ALDH1A1 (0.69) CYP2A13NPC1RAB9AMETAP2PAX8
SCHEMBL20945444 0.71 SIGMAR1 (0.48) HRH3ALDH1A1KMT2AKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011110575-A1 DERIVATIVES OF 2-[2-(BENZO- OR PYRIDO-) THIAZOLYLAMINO]-6-AMINOPYRIDINE, USEFUL IN THE TREATMENT OF RESPIRATORIC, ALLERGIC OR INFLAMMATORY DISEASES GLAXO GROUP LIMITED (GB) 2011-09-15 WO disclosed